QPharma Expands Client Base with Innovative KOL Influence Mapping Solution

MORRISTOWN, N.J.--()--QPharma, a premier provider of compliance and commercial services to the life sciences industry, is expanding its client base for Key Opinion Leader (KOL) solutions. Recently, the firm was contracted by a top-25 pharmaceutical manufacturer for a seven-figure KOL influence mapping project.

QPharma’s KOL solution involves the comprehensive analysis and profiling of healthcare practitioners (HCPs) — as well as the practitioners to whom they are connected — to identify how best to engage them for pharmaceutical medical affairs and promotional purposes. QPharma analyzes all available HCP data sets, including professional, academic, and social as well as clinical activities, to provide clients with powerful insights about influential HCPs and their networks.

“This revolutionary approach, in which we develop a 360-degree profile of each practitioner and their connections, helps QPharma develop a ‘Pyramid of Influence’ of healthcare practitioners in any therapeutic area,” said Badal Shah, Director of Health Analytics at QPharma, who pioneered this solution. “This methodology and concept, which goes beyond traditional KOL engagement, has been very well received by our clients and the overall industry. These business insights enable medical and commercial teams to make faster, more informed decisions as they drive toward their brand launch.”

QPharma’s state-of-the-art KOL profiling tool, Titanium KOL™ (Ti KOL) enables clients to view, filter, and develop reports based on their KOL influence maps. The Ti KOL module is part of the firm’s Titanium™ suite of commercial analytics, intelligence, and reporting tools.

“The addition of this and several other major life sciences firms to our client roster is a testament to the considerable value this intelligence provides,” said QPharma President and CEO Pat Den Boer. “In 2017 and beyond, we expect the demand for these solutions to grow as medical affairs and brand teams gain a deeper understanding of how KOL engagement can accelerate their success.”

More information about Ti KOL and QPharma’s complementary service offerings can be found online, at www.get-titanium.com.

About QPharma, Inc.

Founded in 1994, QPharma provides a suite of solutions to the life sciences industry. Services offered by the company’s Professional Services division include validation services, project management, auditing, and training. The Commercial Services division provides solutions that include sample management and distribution, Sunshine Act transparency reporting, online training, and KOL engagement. Learn more at www.qpharmacorp.com.

Contacts

QPharma, Inc.
Brendan Middleton, 973-656-0011
Director of Marketing and PR
brendan.middleton@qpharmacorp.com

Release Summary

QPharma is expanding its client base for Key Opinion Leader (KOL) solutions and recently added a top-25 pharma company to its client roster.

Contacts

QPharma, Inc.
Brendan Middleton, 973-656-0011
Director of Marketing and PR
brendan.middleton@qpharmacorp.com